Rhabdomyosarcoma Recurrent
1 clinical trials · Condition
◉ Watch Rhabdomyosarcoma Recurrent
| Record | Firm | Date |
|---|---|---|
| Anlotinib Hydrochloride Capsules in Maintenance Treatment for Intermediate-High Risk Rhabdomyosarcoma in Children (NCT07137884) | Sun Yat-sen University | 2025-10-01 |
Track Rhabdomyosarcoma Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.